[HTML][HTML] Neuroimmune interplay during type 2 inflammation: symptoms, mechanisms, and therapeutic targets in atopic diseases

B Kim, ME Rothenberg, X Sun, C Bachert… - Journal of Allergy and …, 2024 - Elsevier
Type 2 inflammation is characterized by overexpression and heightened activity of type 2
cytokines, mediators and cells that drive neuroimmune activation and sensitization to …

Apoptosis and turnover disruption of olfactory sensory neurons in eosinophilic chronic rhinosinusitis

Y Chen, M Li, J Lu - Frontiers in Cellular Neuroscience, 2024 - frontiersin.org
Olfactory dysfunction (OD) is one of the important and difficult-to-treat symptoms of
eosinophilic chronic rhinosinusitis (CRS), which is typically associated with type 2 …

The interleukin-4/interleukin-13 pathway in type 2 inflammation in chronic rhinosinusitis with nasal polyps

C Bachert, A Hicks, S Gane, AT Peters… - Frontiers in …, 2024 - frontiersin.org
Chronic rhinosinusitis with nasal polyps (CRSwNP) is predominantly a type 2 inflammatory
disease associated with type 2 (T2) cell responses and epithelial barrier, mucociliary, and …

Olfactory Loss in Rhinosinusitis: Mechanisms of Loss and Recovery

A Dekeyser, C Huart, T Hummel, V Hox - International Journal of …, 2024 - mdpi.com
Chronic rhinosinusitis (CRS) is a highly prevalent disease and up to 83% of CRS patients
suffer from olfactory dysfunction (OD). Because OD is specifically seen in those CRS …

Reduced Sense of Smell in Patients with Severe Chronic Rhinosinusitis and its Implications for Diagnosis and Management: A Narrative Review

ZM Soler, S Nash, AP Lane, ZM Patel, SE Lee… - Advances in …, 2024 - Springer
Reduced sense of smell is a common symptom in patients with chronic rhinosinusitis (CRS).
Although it is often under-diagnosed by healthcare providers, reduced sense of smell can …

Dupilumab improves sense of smell and clinical outcomes in patients with severe chronic rhinosinusitis with nasal polyps with anosmia

AP Lane, J Mullol, C Hopkins, WJ Fokkens… - Current Medical …, 2024 - Taylor & Francis
Objective Loss of sense of smell is a cardinal symptom of chronic rhinosinusitis with nasal
polyps (CRSwNP) and significantly impacts health-related quality-of-life. Dupilumab …

Association between smell loss, disease burden, and dupilumab efficacy in chronic rhinosinusitis with nasal polyps

ZM Soler, ZM Patel, J Mullol, J Mattos… - American Journal of …, 2025 - journals.sagepub.com
Objective To evaluate the association between smell loss and other aspects of disease, and
evaluate dupilumab efficacy in patients with severe chronic rhinosinusitis with nasal polyps …

Biologikatherapie bei schwer erkrankten Patienten mit „NSAID-exacerbated respiratory disease “und stattgehabter ASS‑Desaktivierung

AR Staufenberg, HK Frankenberger… - HNO, 2024 - Springer
Zusammenfassung Hintergrund Die chronische Rhinosinusitis mit Nasenpolypen
(CRSwNP) ist eine chronisch-entzündliche Erkrankung der oberen Atemwege mit starker …

[PDF][PDF] Uncovering the hidden burden: Understanding loss of smell in CRSwNP

P Hellings - campus.sanofi
• Results from an anonymised survey demonstrated that olfactory dysfunction was the most
impactful symptom on patients' quality of life (QoL), with 71% of patients with CRSwNP …

Uncovering the Hidden Burden: Understanding Loss of Smell in CRSwNP

STM Content - campus.sanofi
Chronic rhinosinusitis with nasal polyps (CRSwNP) is a prevalent condition that significantly
impacts the quality of life for many individuals, particularly through the loss of smell. This …